ESMO: Older Women Too Can Benefit from Trastuzumab (CME/CE)

posted on Oct 10 by in the Uncategorized category MILAN (MedPage Today) -- Women in their 70s and 80s diagnosed with metastatic breast cancer appear to benefit from treatment with trastuzumab (Herceptin), researchers reported here.

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes